Our Logo

Faculty of Sport and Exercise Medicine UK
Excellence in Musculoskeletal Medicine, Exercise Medicine and Team Care

MEMBER LOGIN

follow us:


Instragram Logo

Instragram Logo

Youtube Logo

Google Plus Logo

0131 527 1612

Our Logo

Instragram Logo

Instragram Logo

Youtube Logo

Google Plus Logo

0131 527 1612

MEMBER LOGIN


  • Home
  • About Us
    • Our Role in Healthcare
    • Our Aims
    • Who’s Who
    • Governance
    • Privacy
  • Standards  Publications
    • Position Statements
    • Professional Code
    • Publications
    • Useful Resources
    • Infographics
  • News  Public Affairs
    • News
    • Policy  Public Affairs
    • Blog
    • Media Hub
    • SEM in the News
    • For Patients
  • Careers  Training
    • Careers
    • Membership Exam
    • Training Pathways (Higher Speciality Training)
    • Appraisal  Revalidation Service
    • Events
    • Annual Conference
    • CPD
    • Ultrasound
    • Visiting Fellowship
    • Undergraduates – USEMS
  • Membership
    • Becoming a Member or Fellow
    • Membership Benefits
    • Membership Categories
    • Subscription Fees
  • Contact Us

FSEM Mobile Strapline

Home > Exertional Heat Stroke

Categories

  • Blog
    • Conferences
    • General
    • Training
  • News
  • Policy & Publications
  • Uncategorised

Archive

  • November 2018
  • October 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • View all archives

Exertional Heat Stroke

Position Statement

The Faculty of Sport and Exercise Medicine (FSEM) UK has produced a guide for the immediate recognition and treatment of exertional heatstroke (EHS). EHS is a potentially fatal hyperthermia that occurs in exercising individuals, characterised by central neurological dysfunction and a markedly elevated core temperature (above 40.5°C). There is a significant risk of short- and long-term complications, particularly if there are delays in recognition and treatment. Rapid recognition and urgent treatment is therefore a priority.

Assessment of risk

1. It is vital that athletes, medical staff, and event organisers are aware of the potential risks of developing EHS during exercise, as well as the risk factors which may increase the likelihood of developing the condition. EHS is more common in warm and humid conditions with low wind speeds, where evaporation of sweat is a less effective mechanism for cooling. EHS may also occur in cooler conditions, however, where factors such as clothing and protective garments and the intensity of exercise may contribute. Vigilance is therefore required even in conditions of apparent low climatic stress. A wet-bulb globe temperature (WBGT) estimates the effect of temperature, humidity and solar radiation, and, if available, its use is recommended in assessing the risk of EHS.

Diagnosis

2. The diagnosis of EHS should be considered in any collapsed athlete, especially if there are signs of central nervous system (CNS) dysfunction (for example, confusion, irritability or acting out of character). A diagnosis of EHS can be made if these CNS signs are accompanied by a reliable measurement of a core temperature indicating hyperthermia (greater than 40.5°C). Medical staff should be aware that EHS may present with paradoxical signs of shivering and cool peripheries with poor perfusion. A rectal temperature is the recommended core temperature measurement in the field, and should be obtained in any collapsed or confused athlete where CNS recovery does not occur promptly with the cessation of exercise; peripheral methods of temperature measurement, including aural thermometers, may give false negative or erroneous readings.

Exertional heat illness (EHI) is a spectrum of heat disorders which includes EHS, but can occur at lower temperatures. If the history and presentation are compatible with a diagnosis of EHS, but rectal temperature measurement is not possible, delayed, or raised but below 40.5°C, then empiric treatment should be strongly considered.

Treatment

3. Heat stroke is a medical emergency and rapid onsite cooling intervention is required. Cold or ice-water immersion (CWI) is the most effective method of cooling a hyperthermic patient [1], which requires advance planning of the necessary resources and manpower.

If CWI is not available or practical (for example, if the athlete is agitated, or procedures need to be performed), then an alternative method is to spray the athlete with atomised water or wrap the athlete in wet towels whilst continuously fanning. Both methods are effective, by generating large heat losses; simultaneous fanning is recommended to enhance convective losses.

Immersing the athlete’s hands and feet in cool water can also be used as an adjunct. Ice packs provide some cooling, and are useful when combined with another method, but are less effective in isolation than the above methods. Cool IV fluids may also be beneficial, if available and appropriate to be given.

Commercially produced cooling jackets are available. Research into their efficacy is ongoing.

4. Athletes may be critically unwell with cardiorespiratory failure and severe neurological disturbance (for example, agitation, seizures, or a reduced level of consciousness) and may require emergent, life-saving treatment. Active cooling should take place concurrent with the life-saving treatment, or be started as soon as possible thereafter.

5. The aim of treatment is to reduce further metabolic heat production as quickly as possible and prevent organ damage. Targets for treatment should be a resolution of confusion and a core temperature below 38.5-39°C [2]. There is a risk of developing hypothermia during active cooling, and this may cause further metabolic heat production through the onset of shivering. Regular core temperature monitoring (for example, with an indwelling thermistor) is therefore important.

6. Unless patients fully recover rapidly after onsite cooling, they should be transferred to hospital. The decision to discharge without hospital assessment should be based on return to normothermia, normal neurocognitive function, and normal physical and biochemical parameters. Transfer to hospital should occur while cooling is maintained and life-saving interventions are performed.

7. Medical teams should be aware of the rare association with Malignant Hyperthermia (MH) muscle types. If sedation or anaesthesia is required, drugs which are known to trigger MH (for example, suxamethonium), should be avoided. The routine use of dantrolene is not currently recommended.

Complications and follow-up

8. Field and hospital medical teams should be aware of the complications of EHS, many of which may not be evident in the field setting and may present later, commonly in the first 24 to 48 hours. Initial blood biochemistry within the first few hours after EHS collapse may be normal and it is advisable to repeat the tests if symptoms are prolonged or delayed complications arise. Some of the complications of EHS are related to the systemic inflammatory response syndrome (SIRS) and include rhabdomyolysis and neurocognitive dysfunction, as well as renal, liver and multiple organ failure. Neurocognitive dysfunction includes disorientation and confusion, which may be chronic.

9. Following an episode of EHS, athletes should be followed up with clinical examination and repeat blood tests to ensure resolution of biochemical derangement. They should be advised to avoid all exercise for at least a week. When returning to exercise, the athlete may gradually increase exercise in a cool environment. Acclimatisation to exercise in the heat usually takes at least a further two weeks, and may be much longer. Guidance from a sports and exercise medicine physician may be useful if there are persisting clinical or biochemical abnormalities, or if return to exercise proves difficult. Heat tolerance testing may be useful, where facilities exist.

10. Athletes who have had an episode of EHS should be educated on the risk of developing further episodes.

©Faculty of Sport and Exercise Medicine UK, first published March 2014, reviewed and updated May 2018, next review due May 2021.

Authors: Dr Edward Walter, Dr Rob Galloway, Dr Mike Stacey, Dr Dan Martin, Dr Dan Roiz de sa, Dr Brian Robertson, Dr Courtney Kipps

References:

  1. McDermott BP, Casa DJ, Ganio MS, Lopez RM, Yeargin SW, Armstrong LE, Maresh CM. Acute whole-body cooling for exercise-induced hyperthermia: a systematic review. J Athl Train 2009; 44(1): 84-93
  2. Gagnon D, Lemire BB, Casa DJ, Kenny GP. Cold-water immersion and the treatment of hyperthermia: using 38.6°C as a safe rectal temperature cooling limit. J Athl Train 2010; 45(5): 439-44
  3. Belval LN, Casa DJ, Adams WM, Chiampas GT, Holschen JC, Hosokawa Y, Jardine J, Kane SF, Labotz M, Lemieux RS, McClaine KB, Nye NS, O’Connor FG, Prine B, Raukar NP, Smith MS, Stearns RL. Consensus Statement – Prehospital Care of Exertional Heat Stroke. Prehospital Emergency Care. 2018.

Terms of Use

Position statements published by the FSEM (UK) are quick reference or information documents for the Sport and Exercise Medicine and healthcare community. They can include up to ten points of clinical relevance and are designed to be useful short reference documents.

The FSEM (UK) will publish updates to its official position statements as and when new information is available. The current versions will appear on the website, including the date published, and will supersede and replace prior versions. FSEM UK does not circulate or endorse out of date versions of its position statements.

Our position statements are freely available to the medical and healthcare profession and are subject to copyright, if you plan to use or share them, please ensure you include an up to date version of the statement and credit the Faculty of Sport and Exercise Medicine UK.

Categories

  • Blog
    • Conferences
    • General
    • Training
  • News
  • Policy & Publications
  • Uncategorised

Archive

  • November 2018
  • October 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • June 2013
  • May 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • August 2012

Excellence in Musculoskeletal Medicine, Exercise Medicine and Team Care

follow us:

Instragram Logo

Instragram Logo

Youtube Logo

Google Plus Logo

MEMBERS LOGIN

USEFUL LINKS

  • National Centre for Sport and Exercise Medicine (NCSEM)
  • British Association of Sport and Exercise Medicine (BASEM)
  • FSEM in Ireland
  • British Association of Sport and Exercise Sciences (BASES)
  • UK Physical Activity Guidelines

CONTACT US

The Faculty of Sport
and Exercise Medicine
6 Hill Square
Edinburgh
EH8 9DR

Tel: 0131 527 1612
Email:  [email protected]

Follow FSEM_UK on Twitter

  • RT @dundeesportsmed: Amazing what can happen when you put influential & motivated colleagues from all walks of life into a room… thanks…

Follow us

© The Faculty of Sport and Exercise Medicine. Privacy Policy

Site by Phew